Literature DB >> 12019422

Microvascular rheology of Definity microbubbles after intra-arterial and intravenous administration.

Jonathan R Lindner1, Ji Song, Ananda R Jayaweera, Jiri Sklenar, Sanjiv Kaul.   

Abstract

The microvascular rheology and extent of pulmonary retention of second-generation microbubble ultrasound contrast agents has not previously been well characterized. We assessed the microvascular behavior of Definity, a lipid-shelled microbubble agent containing perfluoropropane gas, using intravital microscopy of either rat spinotrapezius muscle or mouse cremaster muscle. Immediately after intra-arterial injection, which was performed to model pulmonary retention, larger microbubbles (> 5 microm) were entrapped within small arterioles and capillaries. The retention fraction of microbubbles was low (1.2% +/- 0.1%) and entrapment was transient (85% dislodged by 10 minutes), resulting in no adverse hemodynamic effects. Leukocyte or platelet adhesion at the site of entrapment was not seen. After intravenous injection, no microbubble entrapment was observed and the velocities of microbubbles in arterioles, venules, and capillaries correlated well with those of red blood cells. We conclude that after intravenous injection and pulmonary passage, the microvascular rheology of Definity microbubbles is similar to that of red blood cells. Microbubble entrapment within the pulmonary microcirculation after venous injection should be negligible and transient. These findings are important for establishing the safety of this agent.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12019422     DOI: 10.1067/mje.2002.117290

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  76 in total

1.  Magnetic stents retain nanoparticle-bound antirestenotic drugs transported by lipid microbubbles.

Authors:  T Räthel; H Mannell; J Pircher; B Gleich; U Pohl; F Krötz
Journal:  Pharm Res       Date:  2011-12-22       Impact factor: 4.200

Review 2.  Molecular imaging with contrast enhanced ultrasound.

Authors:  Scott M Chadderdon; Sanjiv Kaul
Journal:  J Nucl Cardiol       Date:  2010-08       Impact factor: 5.952

Review 3.  Echocardiographic insights into regional flow-function relationships in coronary artery disease.

Authors:  Sanjiv Kaul
Journal:  J Nucl Cardiol       Date:  2005 Mar-Apr       Impact factor: 5.952

4.  Phasic changes in arterial blood volume is influenced by collateral blood flow: implications for the quantification of coronary stenosis at rest.

Authors:  Marco Pascotto; Kevin Wei; Antonio Micari; Thanjavur Bragadeesh; Norman Craig Goodman; Sanjiv Kaul
Journal:  Heart       Date:  2006-09-27       Impact factor: 5.994

5.  A stimulus-responsive contrast agent for ultrasound molecular imaging.

Authors:  Mark A Borden; Hua Zhang; Robert J Gillies; Paul A Dayton; Katherine W Ferrara
Journal:  Biomaterials       Date:  2007-10-30       Impact factor: 12.479

Review 6.  Molecular imaging of cardiovascular disease with contrast-enhanced ultrasonography.

Authors:  Jonathan R Lindner
Journal:  Nat Rev Cardiol       Date:  2009-06-09       Impact factor: 32.419

7.  Effects of high-fat diet and losartan on renal cortical blood flow using contrast ultrasound imaging.

Authors:  Anne-Emilie Declèves; Joshua J Rychak; Dan J Smith; Kumar Sharma
Journal:  Am J Physiol Renal Physiol       Date:  2013-09-18

Review 8.  [Ultrasound contrast agents. Pharmaceutical drug safety and bioeffects].

Authors:  M Krix; J W Jenne
Journal:  Radiologe       Date:  2007-09       Impact factor: 0.635

9.  Evaluation of the effect of myocardial perfusion after percutaneous coronary intervention in coronary artery disease by using intracoronary myocardial contrast echocardiography and two other angiographic techniques.

Authors:  Hong Wang; Lan Huang; Jun Jin; Yaoming Song; Zhaohua Geng; Xuejun Yu; Jun Qin; Gang Zhao; Yunhua Gao; Zheng Liu; Li Yang
Journal:  Front Med China       Date:  2007-02-01

Review 10.  Liquid perfluorocarbons as contrast agents for ultrasonography and (19)F-MRI.

Authors:  Raquel Díaz-López; Nicolas Tsapis; Elias Fattal
Journal:  Pharm Res       Date:  2009-11-10       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.